Survival Outcomes After High-dose Chemotherapy and Stem Cell Transplantation in the Salvage Setting for Relapsed or Refractory Germ Cell Cancers

Conclusion: In relapsed GCT patients, median survival may exceed 5 years post-HDCT and SCT.

Source: In Vivo - November 3, 2020 Category: Research Authors: SHARMA, A., BABRA, D. S., JOSHI, P. V., HALL, M., GOGBASHIAN, A., VASDEV, N., JOSEPH, M., YAZDAN, A., KANFER, E. Tags: Clinical Studies Source Type: research